• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TNC 以 METTL3 依赖的方式加速低氧诱导的心脏损伤。

TNC Accelerates Hypoxia-Induced Cardiac Injury in a METTL3-Dependent Manner.

机构信息

Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

Shanghai Institute of Cardiovascular Diseases, Shanghai 200032, China.

出版信息

Genes (Basel). 2023 Feb 26;14(3):591. doi: 10.3390/genes14030591.

DOI:10.3390/genes14030591
PMID:36980863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10048594/
Abstract

Cardiac fibrosis and cardiomyocyte apoptosis are reparative processes after myocardial infarction (MI), which results in cardiac remodeling and heart failure at last. Tenascin-C (TNC) consists of four distinct domains, which is a large multimodular glycoprotein of the extracellular matrix. It is also a key regulator of proliferation and apoptosis in cardiomyocytes. As a significant mA regulator, METTL3 binds mA sites in mRNA to control its degradation, maturation, stabilization, and translation. Whether METTL3 regulates the occurrence and development of myocardial infarction through the mA modification of TNC mRNA deserves our study. Here, we have demonstrated that overexpression of METTL3 aggravated cardiac dysfunction and cardiac fibrosis after 4 weeks after MI. Moreover, we also demonstrated that TNC resulted in cardiac fibrosis and cardiomyocyte apoptosis after MI. Mechanistically, METTL3 led to enhanced mA levels of TNC mRNA and promoted TNC mRNA stability. Then, we mutated one mA site "A" to "T", and the binding ability of METTL3 was reduced. In conclusion, METTL3 is involved in cardiac fibrosis and cardiomyocyte apoptosis by increasing mA levels of TNC mRNA and may be a promising target for the therapy of cardiac fibrosis after MI.

摘要

心肌纤维化和心肌细胞凋亡是心肌梗死后的修复过程,最终导致心脏重构和心力衰竭。Tenascin-C(TNC)由四个不同的结构域组成,是细胞外基质中的一种大型多功能糖蛋白。它也是心肌细胞增殖和凋亡的关键调节因子。作为一个重要的 mA 调节因子,METTL3 通过结合 mRNA 中的 mA 位点来控制其降解、成熟、稳定和翻译。METTL3 是否通过 TNC mRNA 的 mA 修饰来调节心肌梗死的发生和发展值得我们研究。在这里,我们已经证明,METTL3 的过表达在心肌梗死后 4 周时加重了心脏功能障碍和心脏纤维化。此外,我们还证明 TNC 在心肌梗死后导致心脏纤维化和心肌细胞凋亡。从机制上讲,METTL3 通过增加 TNC mRNA 的 mA 水平导致 TNC mRNA 的稳定性增强。然后,我们将一个 mA 位点“ A”突变为“ T”,METTL3 的结合能力降低。总之,METTL3 通过增加 TNC mRNA 的 mA 水平参与心肌纤维化和心肌细胞凋亡,可能是心肌梗死后心脏纤维化治疗的有希望的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/547b/10048594/7423b77dafce/genes-14-00591-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/547b/10048594/70a0a4c8e9dc/genes-14-00591-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/547b/10048594/444a8d1086c7/genes-14-00591-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/547b/10048594/b51b41df1fc5/genes-14-00591-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/547b/10048594/6d5f4b9b052e/genes-14-00591-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/547b/10048594/7423b77dafce/genes-14-00591-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/547b/10048594/70a0a4c8e9dc/genes-14-00591-g001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/547b/10048594/444a8d1086c7/genes-14-00591-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/547b/10048594/b51b41df1fc5/genes-14-00591-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/547b/10048594/6d5f4b9b052e/genes-14-00591-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/547b/10048594/7423b77dafce/genes-14-00591-g005.jpg

相似文献

1
TNC Accelerates Hypoxia-Induced Cardiac Injury in a METTL3-Dependent Manner.TNC 以 METTL3 依赖的方式加速低氧诱导的心脏损伤。
Genes (Basel). 2023 Feb 26;14(3):591. doi: 10.3390/genes14030591.
2
Mettl3-mediated mA modification of Fgf16 restricts cardiomyocyte proliferation during heart regeneration.Mettl3 介导的 Fgf16 的 mA 修饰限制心脏再生过程中心肌细胞的增殖。
Elife. 2022 Nov 18;11:e77014. doi: 10.7554/eLife.77014.
3
Programmed Release METTL3-14 Inhibitor Microneedle Protects Myocardial Function by Reducing Drp1 m6A Modification-Mediated Mitochondrial Fission.程序性释放 METTL3-14 抑制剂微针通过减少 Drp1 m6A 修饰介导的线粒体分裂来保护心肌功能。
ACS Appl Mater Interfaces. 2023 Oct 11;15(40):46583-46597. doi: 10.1021/acsami.3c06318. Epub 2023 Sep 26.
4
METTL3 boosts mitochondrial fission and induces cardiac fibrosis after ischemia/reperfusion injury.METTL3 促进缺血/再灌注损伤后的线粒体分裂并诱导心脏纤维化。
Int J Biol Sci. 2024 Jan 1;20(2):433-445. doi: 10.7150/ijbs.87535. eCollection 2024.
5
MetBil as a novel molecular regulator in ischemia-induced cardiac fibrosis via METTL3-mediated m6A modification.MetBil 作为一种新型分子调节剂,通过 METTL3 介导的 m6A 修饰在缺血性诱导的心脏纤维化中发挥作用。
FASEB J. 2023 Mar;37(3):e22797. doi: 10.1096/fj.202201734R.
6
Silencing of METTL3 attenuates cardiac fibrosis induced by myocardial infarction via inhibiting the activation of cardiac fibroblasts.沉默 METTL3 通过抑制心肌成纤维细胞的激活来减轻心肌梗死后的心脏纤维化。
FASEB J. 2021 Feb;35(2):e21162. doi: 10.1096/fj.201903169R. Epub 2020 Nov 5.
7
Extracellular vesicle-packaged mitochondrial disturbing miRNA exacerbates cardiac injury during acute myocardial infarction.细胞外囊泡包裹的扰乱线粒体的微小 RNA 在急性心肌梗死期间加重心脏损伤。
Clin Transl Med. 2022 Apr;12(4):e779. doi: 10.1002/ctm2.779.
8
Interaction between cell and extracellular matrix in heart disease: multiple roles of tenascin-C in tissue remodeling.心脏病中细胞与细胞外基质的相互作用:肌腱蛋白-C在组织重塑中的多重作用
Histol Histopathol. 2004 Apr;19(2):517-25. doi: 10.14670/HH-19.517.
9
Tenascin-C in cardiac disease: a sophisticated controller of inflammation, repair, and fibrosis.Tenascin-C 在心脏疾病中的作用:炎症、修复和纤维化的复杂控制器。
Am J Physiol Cell Physiol. 2020 Nov 1;319(5):C781-C796. doi: 10.1152/ajpcell.00353.2020. Epub 2020 Aug 26.
10
METTL3 achieves lipopolysaccharide-induced myocardial injury via mA-dependent stabilization of Myh3 mRNA.METTL3 通过 mA 依赖性稳定 Myh3 mRNA 实现脂多糖诱导的心肌损伤。
Biochim Biophys Acta Mol Cell Res. 2023 Oct;1870(7):119503. doi: 10.1016/j.bbamcr.2023.119503. Epub 2023 May 27.

引用本文的文献

1
METTL3-mediated m⁶A methylation in cardiac diseases: pathogenic roles and therapeutic potential.METTL3介导的m⁶A甲基化在心脏疾病中的致病作用及治疗潜力
Cell Biol Toxicol. 2025 May 20;41(1):87. doi: 10.1007/s10565-025-10039-1.
2
Epigenetic modifications in cardiac fibrosis: recent evidence of new pharmacological targets.心脏纤维化中的表观遗传修饰:新药理学靶点的最新证据
Front Mol Biosci. 2025 May 2;12:1583446. doi: 10.3389/fmolb.2025.1583446. eCollection 2025.
3
m6A Ribonucleic Acid Methylation in Fibrotic Diseases of Visceral Organs.

本文引用的文献

1
Modulating Lysine Crotonylation in Cardiomyocytes Improves Myocardial Outcomes.调节心肌细胞中的赖氨酸巴豆酰化可改善心肌结局。
Circ Res. 2022 Aug 19;131(5):456-472. doi: 10.1161/CIRCRESAHA.122.321054. Epub 2022 Aug 3.
2
METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma.METTL14 介导的 MN1 mRNA 转录后修饰促进骨肉瘤的致瘤性和全反式维甲酸耐药性。
EBioMedicine. 2022 Aug;82:104142. doi: 10.1016/j.ebiom.2022.104142. Epub 2022 Jul 7.
3
Inhibition of attenuates renal injury and inflammation by alleviating m6A modifications via IGF2BP2-dependent mechanisms.
内脏器官纤维化疾病中的m6A核糖核酸甲基化
Small Sci. 2024 Nov 21;5(2):2400308. doi: 10.1002/smsc.202400308. eCollection 2025 Feb.
4
The Emerging Role of m6A and Programmed Cell Death in Cardiovascular Diseases.m6A与程序性细胞死亡在心血管疾病中的新兴作用
Biomolecules. 2025 Feb 8;15(2):247. doi: 10.3390/biom15020247.
5
m6A RNA modification pathway: orchestrating fibrotic mechanisms across multiple organs.m6A RNA修饰途径:协调多个器官的纤维化机制
Brief Funct Genomics. 2025 Jan 15;24. doi: 10.1093/bfgp/elae051.
6
N6-methyladenosine (m6A) RNA modification in fibrosis and collagen-related diseases.N6-甲基腺苷(m6A)RNA 修饰在纤维化和胶原相关疾病中的作用。
Clin Epigenetics. 2024 Sep 12;16(1):127. doi: 10.1186/s13148-024-01736-5.
7
The potential of RNA methylation in the treatment of cardiovascular diseases.RNA甲基化在心血管疾病治疗中的潜力。
iScience. 2024 Jul 20;27(8):110524. doi: 10.1016/j.isci.2024.110524. eCollection 2024 Aug 16.
8
Tenascin C activates the toll‑like receptor 4/NF‑κB signaling pathway to promote the development of polycystic ovary syndrome.Tenascin C 通过激活 toll 样受体 4/NF-κB 信号通路促进多囊卵巢综合征的发生。
Mol Med Rep. 2024 Jun;29(6). doi: 10.3892/mmr.2024.13230. Epub 2024 Apr 26.
通过 IGF2BP2 依赖性机制减轻 m6A 修饰,抑制 可减轻肾脏损伤和炎症。
Sci Transl Med. 2022 Apr 13;14(640):eabk2709. doi: 10.1126/scitranslmed.abk2709.
4
MdMTA-mediated m A modification enhances drought tolerance by promoting mRNA stability and translation efficiency of genes involved in lignin deposition and oxidative stress.MdMTA介导的m⁶A修饰通过促进参与木质素沉积和氧化应激的基因的mRNA稳定性和翻译效率来增强耐旱性。
New Phytol. 2022 May;234(4):1294-1314. doi: 10.1111/nph.18069. Epub 2022 Mar 26.
5
Atheroprotective mechanism by which folic acid regulates monocyte subsets and function through DNA methylation.叶酸通过 DNA 甲基化调节单核细胞亚群和功能的抗动脉粥样硬化机制。
Clin Epigenetics. 2022 Feb 28;14(1):32. doi: 10.1186/s13148-022-01248-0.
6
Dynamic assembly of the mRNA m6A methyltransferase complex is regulated by METTL3 phase separation.mRNA m6A 甲基转移酶复合物的动态组装受 METTL3 相分离的调控。
PLoS Biol. 2022 Feb 10;20(2):e3001535. doi: 10.1371/journal.pbio.3001535. eCollection 2022 Feb.
7
Continuous Infusion of Angiotensin IV Protects against Acute Myocardial Infarction via the Inhibition of Inflammation and Autophagy.血管紧张素 IV 持续输注通过抑制炎症和自噬保护急性心肌梗死。
Oxid Med Cell Longev. 2021 Dec 14;2021:2860488. doi: 10.1155/2021/2860488. eCollection 2021.
8
PINK1 deficiency impairs osteoblast differentiation through aberrant mitochondrial homeostasis.PINK1 缺失通过异常的线粒体动态平衡损害成骨细胞分化。
Stem Cell Res Ther. 2021 Nov 25;12(1):589. doi: 10.1186/s13287-021-02656-4.
9
METTL3 improves cardiomyocyte proliferation upon myocardial infarction via upregulating miR-17-3p in a DGCR8-dependent manner.METTL3通过以DGCR8依赖的方式上调miR-17-3p来改善心肌梗死后的心肌细胞增殖。
Cell Death Discov. 2021 Oct 13;7(1):291. doi: 10.1038/s41420-021-00688-6.
10
Loss of mA methyltransferase METTL3 promotes heart regeneration and repair after myocardial injury.mA 甲基转移酶 METTL3 的缺失促进心肌损伤后的心脏再生和修复。
Pharmacol Res. 2021 Dec;174:105845. doi: 10.1016/j.phrs.2021.105845. Epub 2021 Aug 21.